{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:09:04Z","timestamp":1749625744682},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T00:00:00Z","timestamp":1565308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,9,1]]},"DOI":"10.1007\/s00120-019-1012-4","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:05:06Z","timestamp":1565341506000},"page":"1093-1106","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nachsorge des muskelinvasiven Harnblasenkarzinoms nach kurativer Therapie"],"prefix":"10.1007","volume":"58","author":[{"given":"G. B.","family":"Schulz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Schlenker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"issue":"10","key":"1012_CR1","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/iju.13164","volume":"23","author":"Q Alimi","year":"2016","unstructured":"Alimi\u00a0Q et\u00a0al (2016) Role of routine computed tomography scan in the oncological follow up of patients treated by radical cystectomy for bladder cancer. Int J Urol 23(10):840\u2013846","journal-title":"Int J Urol"},{"issue":"12","key":"1012_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.ejso.2013.12.017","volume":"40","author":"JA Nieuwenhuijzen","year":"2014","unstructured":"Nieuwenhuijzen\u00a0JA et al (2014) Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy. Eur J Surg Oncol 40(12):1677\u20131685","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"1012_CR3","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.acuro.2013.01.005","volume":"37","author":"J Huguet","year":"2013","unstructured":"Huguet\u00a0J (2013) Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors. Actas Urol Esp 37(6):376\u2013382","journal-title":"Actas Urol Esp"},{"issue":"5","key":"1012_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0302-2838(03)00100-3","volume":"43","author":"E Solsona","year":"2003","unstructured":"Solsona\u00a0E et\u00a0al (2003) Late oncological occurrences following radical cystectomy in patients with bladder cancer. Eur Urol 43(5):489\u2013494","journal-title":"Eur Urol"},{"issue":"6","key":"1012_CR5","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.eururo.2011.08.030","volume":"60","author":"SA Boorjian","year":"2011","unstructured":"Boorjian\u00a0SA et\u00a0al (2011) Risk factors and outcomes of urethral recurrence following radical cystectomy. Eur Urol 60(6):1266\u20131272","journal-title":"Eur Urol"},{"issue":"2","key":"1012_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.urolonc.2017.11.007","volume":"36","author":"O Fahmy","year":"2018","unstructured":"Fahmy\u00a0O et al (2018) Urethral recurrence after radical cystectomy for urothelial carcinoma: a systematic review and meta-analysis. Urol Oncol 36(2):54\u201359","journal-title":"Urol Oncol"},{"issue":"4","key":"1012_CR7","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.eururo.2016.09.035","volume":"71","author":"G Gakis","year":"2017","unstructured":"Gakis\u00a0G et\u00a0al (2017) Systematic review on the fate of the remnant Urothelium after radical Cystectomy. Eur Urol 71(4):545\u2013557","journal-title":"Eur Urol"},{"issue":"5","key":"1012_CR8","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.urology.2004.06.012","volume":"64","author":"AM Nieder","year":"2004","unstructured":"Nieder\u00a0AM et\u00a0al (2004) Urethral recurrence after cystoprostatectomy: implications for urinary diversion and monitoring. Urology 64(5):950\u2013954","journal-title":"Urology"},{"issue":"4","key":"1012_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1097\/01.ju.0000149679.56884.0f","volume":"173","author":"JP Stein","year":"2005","unstructured":"Stein\u00a0JP et\u00a0al (2005) Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J\u00a0Urol 173(4):1163\u20131168","journal-title":"J Urol"},{"issue":"6","key":"1012_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1442-2042.2007.01776.x","volume":"14","author":"J Furukawa","year":"2007","unstructured":"Furukawa\u00a0J et\u00a0al (2007) Upper urinary tract recurrence following radical cystectomy for bladder cancer. Int J Urol 14(6):496\u2013499","journal-title":"Int J Urol"},{"issue":"5","key":"1012_CR11","doi-asserted-by":"publisher","first-page":"e96467","DOI":"10.1371\/journal.pone.0096467","volume":"9","author":"SH Kim","year":"2014","unstructured":"Kim\u00a0SH et\u00a0al (2014) A retrospective analysis of incidence and its associated risk factors of upper urinary tract recurrence following radical cystectomy for bladder cancer with transitional cell carcinoma: the significance of local pelvic recurrence and positive lymph node. PLoS ONE 9(5):e96467","journal-title":"PLoS ONE"},{"issue":"6","key":"1012_CR12","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1016\/j.juro.2007.08.041","volume":"178","author":"C Meissner","year":"2007","unstructured":"Meissner\u00a0C et\u00a0al (2007) The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer. J\u00a0Urol 178(6):2287\u20132290","journal-title":"J Urol"},{"issue":"1","key":"1012_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00345-012-0905-2","volume":"31","author":"N Perlis","year":"2013","unstructured":"Perlis\u00a0N et al (2013) Upper urinary tract and urethral recurrences following radical cystectomy: review of risk factors and outcomes between centres with different follow-up protocols. World J Urol 31(1):161\u2013167","journal-title":"World J Urol"},{"issue":"3","key":"1012_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1442-2042.2011.02916.x","volume":"19","author":"A Takayanagi","year":"2012","unstructured":"Takayanagi\u00a0A et\u00a0al (2012) Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors. Int J Urol 19(3):229\u2013233","journal-title":"Int J Urol"},{"issue":"9","key":"1012_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.urolonc.2018.01.014","volume":"36","author":"TCM Zuiverloon","year":"2018","unstructured":"Zuiverloon\u00a0TCM et al (2018) Recommendations for follow-up of muscle-invasive bladder cancer patients: a consensus by the international bladder cancer network. Urol Oncol 36(9):423\u2013431","journal-title":"Urol Oncol"},{"issue":"5","key":"1012_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00345-006-0117-8","volume":"24","author":"SM Donat","year":"2006","unstructured":"Donat\u00a0SM (2006) Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? World J Urol 24(5):557\u2013564","journal-title":"World J Urol"},{"issue":"1","key":"1012_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00120-018-0828-7","volume":"58","author":"GB Schulz","year":"2019","unstructured":"Schulz\u00a0GB et\u00a0al (2019) Value of imaging in upper urinary tract tumors. Urologe A 58(1):5\u201313","journal-title":"Urologe A."},{"issue":"1","key":"1012_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.juro.2009.08.144","volume":"183","author":"LJ Wang","year":"2010","unstructured":"Wang\u00a0LJ et\u00a0al (2010) Multidetector computerized tomography urography is more accurate than excretory urography for diagnosing transitional cell carcinoma of the upper urinary tract in adults with hematuria. J\u00a0Urol 183(1):48\u201355","journal-title":"J Urol"},{"issue":"7","key":"1012_CR19","doi-asserted-by":"publisher","first-page":"e0158673","DOI":"10.1371\/journal.pone.0158673","volume":"11","author":"M Sudah","year":"2016","unstructured":"Sudah\u00a0M et al (2016) Comprehensive MR Urography protocol: equally good diagnostic performance and enhanced visibility of the upper urinary tract compared to triple-phase CT Urography. PLoS ONE 11(7):e158673","journal-title":"PLoS ONE"},{"issue":"3","key":"1012_CR20","doi-asserted-by":"publisher","first-page":"717","DOI":"10.3892\/etm.2015.2187","volume":"9","author":"H Ozturk","year":"2015","unstructured":"Ozturk\u00a0H, Karapolat\u00a0I (2015) Efficacy of (18)F-fluorodeoxyglucose-positron emission tomography\/computed tomography in restaging muscle-invasive bladder cancer following radical cystectomy. Exp Ther Med 9(3):717\u2013724","journal-title":"Exp Ther Med"},{"key":"1012_CR21","series-title":"AWMF-Registrierungsnummer 032\/038OL","volume-title":"S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms, Langversion 1.1","author":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., AWMF)","year":"2016","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, D.K., AWMF) (2016) S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Harnblasenkarzinoms, Langversion 1.1. AWMF-Registrierungsnummer 032\/038OL"},{"issue":"4","key":"1012_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/cncy.21650","volume":"124","author":"H Chen","year":"2016","unstructured":"Chen\u00a0H et\u00a0al (2016) Urine cytology in monitoring recurrence in urothelial carcinoma after radical cystectomy and urinary diversion. Cancer Cytopathol 124(4):273\u2013278","journal-title":"Cancer Cytopathol"},{"issue":"6","key":"1012_CR23","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.urolonc.2010.08.006","volume":"30","author":"MI Fernandez","year":"2012","unstructured":"Fernandez\u00a0MI et\u00a0al (2012) The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer. Urol Oncol 30(6):821\u2013824","journal-title":"Urol Oncol"},{"issue":"5","key":"1012_CR24","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1016\/j.clgc.2017.03.003","volume":"15","author":"R Pichler","year":"2017","unstructured":"Pichler\u00a0R et al (2017) Effect of urinary cytology for detecting recurrence in remnant Urothelium after radical Cystectomy: insights from a\u00a010-year cytology database. Clin Genitourin Cancer 15(5):e783\u2013e791","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"1012_CR25","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.juro.2012.08.017","volume":"188","author":"S Picozzi","year":"2012","unstructured":"Picozzi\u00a0S et al (2012) Upper urinary tract recurrence following radical cystectomy for bladder cancer: a\u00a0meta-analysis on 13,185 patients. J\u00a0Urol 188(6):2046\u20132054","journal-title":"J Urol"},{"issue":"2","key":"1012_CR26","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.juro.2017.08.106","volume":"199","author":"A Sanchez","year":"2018","unstructured":"Sanchez\u00a0A et\u00a0al (2018) Incidence, clinicopathological risk factors, management and outcomes of Nonmuscle invasive recurrence after complete response to Trimodality therapy for muscle invasive bladder cancer. J\u00a0Urol 199(2):407\u2013415","journal-title":"J Urol"},{"issue":"6","key":"1012_CR27","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","volume":"71","author":"NJ Giacalone","year":"2017","unstructured":"Giacalone\u00a0NJ et al (2017) Long-term outcomes after bladder-preserving Tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital Experience. Eur Urol 71(6):952\u2013960","journal-title":"Eur Urol"},{"issue":"4","key":"1012_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.eururo.2008.08.027","volume":"55","author":"E Solsona","year":"2009","unstructured":"Solsona\u00a0E et al (2009) Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a\u00a0phase 2 nonrandomized comparative trial with radical cystectomy. Eur Urol 55(4):911\u2013919","journal-title":"Eur Urol"},{"issue":"6","key":"1012_CR29","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/S0022-5347(06)00322-3","volume":"175","author":"W Kassouf","year":"2006","unstructured":"Kassouf\u00a0W et\u00a0al (2006) Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a\u00a0contemporary review of the M. D. Anderson Cancer Center experience. J\u00a0Urol 175(6):2058\u20132062","journal-title":"J Urol"},{"issue":"4","key":"1012_CR30","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.juro.2012.06.029","volume":"188","author":"JJ Knoedler","year":"2012","unstructured":"Knoedler\u00a0JJ et al (2012) Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J\u00a0Urol 188(4):1115\u20131119","journal-title":"J Urol"},{"issue":"3","key":"1012_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.urology.2008.04.052","volume":"72","author":"MC Smaldone","year":"2008","unstructured":"Smaldone\u00a0MC et al (2008) Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma. Urology 72(3):613\u2013616","journal-title":"Urology"},{"issue":"5","key":"1012_CR32","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/j.juro.2011.07.005","volume":"186","author":"SA Boorjian","year":"2011","unstructured":"Boorjian\u00a0SA et\u00a0al (2011) Detection of asymptomatic recurrence during routine oncological followup after radical cystectomy is associated with improved patient survival. J\u00a0Urol 186(5):1796\u20131802","journal-title":"J Urol"},{"issue":"4","key":"1012_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.eururo.2010.05.041","volume":"58","author":"G Giannarini","year":"2010","unstructured":"Giannarini\u00a0G et al (2010) Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58(4):486\u2013494","journal-title":"Eur Urol"},{"issue":"6","key":"1012_CR34","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1016\/j.juro.2007.01.133","volume":"177","author":"KM Sanderson","year":"2007","unstructured":"Sanderson\u00a0KM et al (2007) Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J\u00a0Urol 177(6):2088\u20132094","journal-title":"J Urol"},{"issue":"2","key":"1012_CR35","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3233\/BLC-170108","volume":"3","author":"V Patel","year":"2017","unstructured":"Patel\u00a0V et al (2017) Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis. Bladder Cancer 3(2):121\u2013132","journal-title":"Bladder Cancer"},{"issue":"5","key":"1012_CR36","doi-asserted-by":"publisher","first-page":"236.e13","DOI":"10.1016\/j.urolonc.2015.11.025","volume":"34","author":"SB Stewart-Merrill","year":"2016","unstructured":"Stewart-Merrill\u00a0SB et al (2016) Oncologic surveillance in bladder cancer following radical cystectomy: a systematic review and meta-analysis. Urol Oncol 34(5):236.e13\u2013236.e21","journal-title":"Urol Oncol"},{"issue":"7","key":"1012_CR37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/jnci\/djt015","volume":"105","author":"AB Apolo","year":"2013","unstructured":"Apolo\u00a0AB et al (2013) Prognostic model for predicting survival of patients with metastatic urothelial cancer treated with cisplatin-based chemotherapy. J\u00a0Natl Cancer Inst 105(7):499\u2013503","journal-title":"J Natl Cancer Inst"},{"issue":"15_suppl","key":"1012_CR38","doi-asserted-by":"publisher","first-page":"4524","DOI":"10.1200\/JCO.2018.36.15_suppl.4524","volume":"36","author":"J Vuky","year":"2018","unstructured":"Vuky\u00a0J et al (2018) Updated efficacy and safety of KEYNOTE-052: A single-arm phase 2 study investigating first-line pembrolizumab (pembro) in cisplatin-ineligible advanced urothelial cancer (UC). J\u00a0Clin Oncol 36(15_suppl):4524\u20134524","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"1012_CR39","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.1200\/JCO.2018.36.15_suppl.4523","volume":"36","author":"AV Balar","year":"2018","unstructured":"Balar\u00a0AV et al (2018) Atezolizumab (atezo) in first-line cisplatin-ineligible or platinum-treated locally advanced or metastatic urothelial cancer (mUC): Long-term efficacy from phase 2 study IMvigor210. J\u00a0Clin Oncol 36(15_suppl):4523\u20134523","journal-title":"J Clin Oncol"},{"issue":"4","key":"1012_CR40","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.juro.2008.11.112","volume":"181","author":"BG Volkmer","year":"2009","unstructured":"Volkmer\u00a0BG et al (2009) Oncological followup after radical cystectomy for bladder cancer-is there any benefit? J\u00a0Urol 181(4):1587\u20131593 (discussion 1593)","journal-title":"J Urol"},{"issue":"2","key":"1012_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","volume":"62","author":"V Soukup","year":"2012","unstructured":"Soukup\u00a0V et al (2012) Follow-up after surgical treatment of bladder cancer: a\u00a0critical analysis of the literature. Eur Urol 62(2):290\u2013302","journal-title":"Eur Urol"},{"key":"1012_CR42","volume-title":"EAU Guideliens on muscle-invasive and metastatic bladder cancer","author":"JA Witjes (Chair)","year":"2019","unstructured":"Witjes (Chair) JA, Bruins, Cathomas, Comp\u00e9rat et al (2019) EAU Guideliens on muscle-invasive and metastatic bladder cancer. EAU Guidelines Office, Arnhem"},{"issue":"4","key":"1012_CR43","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.eururo.2007.09.008","volume":"53","author":"JA Nieuwenhuijzen","year":"2008","unstructured":"Nieuwenhuijzen\u00a0JA et\u00a0al (2008) Urinary diversions after cystectomy: the association of clinical factors, complications and functional results of four different diversions. Eur Urol 53(4):834\u2013842 (discussion 842\u20134)","journal-title":"Eur Urol"},{"issue":"3","key":"1012_CR44","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/01.ju.0000051462.45388.14","volume":"169","author":"S Madersbacher","year":"2003","unstructured":"Madersbacher\u00a0S et al (2003) Long-term outcome of ileal conduit diversion. J\u00a0Urol 169(3):985\u2013990","journal-title":"J Urol"},{"issue":"1","key":"1012_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.eururo.2012.08.050","volume":"63","author":"RE Hautmann","year":"2013","unstructured":"Hautmann\u00a0RE et al (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion. Eur Urol 63(1):67\u201380","journal-title":"Eur Urol"},{"issue":"6","key":"1012_CR46","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.eururo.2010.02.024","volume":"57","author":"N Lawrentschuk","year":"2010","unstructured":"Lawrentschuk\u00a0N et\u00a0al (2010) Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 57(6):983\u20131001","journal-title":"Eur Urol"},{"issue":"8","key":"1012_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrurol.2014.151","volume":"11","author":"RA Modh","year":"2014","unstructured":"Modh\u00a0RA, Mulhall\u00a0JP, Gilbert\u00a0SM (2014) Sexual dysfunction after cystectomy and urinary diversion. Nat Rev Urol 11(8):445\u2013453","journal-title":"Nat Rev Urol"},{"issue":"5","key":"1012_CR48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.eururo.2004.07.009","volume":"46","author":"P Perimenis","year":"2004","unstructured":"Perimenis\u00a0P et al (2004) Ileal orthotopic bladder substitute combined with an afferent tubular segment: long-term upper urinary tract changes and voiding pattern. Eur Urol 46(5):604\u2013609","journal-title":"Eur Urol"},{"issue":"12","key":"1012_CR49","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1111\/j.1464-410X.2007.07366.x","volume":"101","author":"F Suriano","year":"2008","unstructured":"Suriano\u00a0F et\u00a0al (2008) Bacteriuria in patients with an orthotopic ileal neobladder: urinary tract infection or asymptomatic bacteriuria? BJU Int 101(12):1576\u20131579","journal-title":"BJU Int"},{"issue":"4","key":"1012_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S0022-5347(01)61590-8","volume":"161","author":"RD Mills","year":"1999","unstructured":"Mills\u00a0RD, Studer\u00a0UE (1999) Metabolic consequences of continent urinary diversion. J\u00a0Urol 161(4):1057\u20131066","journal-title":"J Urol"},{"issue":"29","key":"1012_CR51","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1200\/JCO.2013.54.3173","volume":"32","author":"A Gupta","year":"2014","unstructured":"Gupta\u00a0A et\u00a0al (2014) Risk of fracture after radical cystectomy and urinary diversion for bladder cancer. J\u00a0Clin Oncol 32(29):3291\u20133298","journal-title":"J Clin Oncol"},{"issue":"1","key":"1012_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3233\/BLC-170140","volume":"4","author":"T Todenhofer","year":"2018","unstructured":"Todenhofer\u00a0T et al (2018) Liquid biopsy-analysis of circulating tumor DNA (ctDNA) in bladder cancer. Bladder Cancer 4(1):19\u201329","journal-title":"Bladder Cancer"},{"issue":"12","key":"1012_CR53","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s00345-017-2068-7","volume":"35","author":"SB Merrill","year":"2017","unstructured":"Merrill\u00a0SB et al (2017) Oncologic surveillance following radical cystectomy: an individualized risk-based approach. World J Urol 35(12):1863\u20131869","journal-title":"World J Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-1012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-019-1012-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-1012-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T23:35:03Z","timestamp":1596843303000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-019-1012-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,1]]}},"alternative-id":["1012"],"URL":"https:\/\/doi.org\/10.1007\/s00120-019-1012-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,9]]},"assertion":[{"value":"9 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>G.B.\u00a0Schulz<\/b>: Finanzielle Interessen: Roche, MSD, IPSEN, Astellas. Nichtfinanzielle Interessen: Assistenzarzt Urologie Klinikum Grosshadern (LMU) | Mitgliedschaften: DGU, EAU. <b>C.G.\u00a0Stief<\/b> gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Mitglied im Wissenschaftsrat | Mitgliedschaften: DGU, EAU, AUA, Bayerische Urologenvereinigung. <b>B.\u00a0Schlenker <\/b>gibt an, dass kein finanzieller Interessenkonflikt besteht. Nichtfinanzielle Interessen: Angestellt als Leitender Oberarzt am Klinikum der Universit\u00e4t M\u00fcnchen, Campus Gro\u00dfhadern.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}